Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

CompletedOBSERVATIONAL
Enrollment

508

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Over Active Bladder
Interventions
DRUG

Fesoterodine

Any dose of Fesoterodine

Trial Locations (37)

1000

Mary Johnston Hospital, Inc., Tondo

Medical Center Manila, Manila

University of Sto. Tomas Hospital, Manila

1100

St. Luke's Medical Center, North Tower, CHBC, Quezon City

F.E.U. - Nicanor Reyes Medical Foundation Medical Center, West Fairview, Quezon City

1101

East Avenue Medical Center, Diliman, Quezon City

1102

St. Luke's Medical Center, Quezon City

1200

Makati Medical Center, Makati City

1605

The Medical City, Pasig

4301

Lucena United Doctors Hospital, Lucena City

Unknown

Private Clinic, Baguio City

Private Clinic, Batangas

Cebu Doctors Hospital, Osmena Blvd.,, Cebu

Private Clinic, City of Muntinlupa

Davao Doctors Hospital, Davao City

Davao Doctors Tower, Davao City

Davao Medical School Foundation Hospital, Davao City

Private Clinic, Davao City

Room 120, Davao Medical School Foundation Hospital, Davao City

Private Clinic, Ilocos Norte

Private Clinic, La Union

Private Clinic, Laguna

Private Clinic, Makati City

Room 314 Main Building, Makati City

VRPMC, Mandaluyong

Ospital ng Maynila Medical Center, Manila

Private Clinic, Manila

Santo Tomas University Hospital, Manila

Private Clinic, Nueva Ecija

Healthway Medical, The Block, Philippines

East Avenue Medical Center, Quezon

Private Clinic, Quezon

Private Clinic, Quezon City

Private Clinic, South Luzon

Central Luzon Doctor's Hospital, Tarlac City

Fatima Medical Center, Inc., Valenzuela

Urology Clinic, Zamboanga City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY